-
Anup Singh, PhD,
La Jolla Institute for Immunology
Mentored Investigator Grant
Studying the Role of BRCA1 in Regulating Heterochromatin Structure and Function in Ovarian Cancer
-
Melanie Weigert, PhD,
University of Chicago
Mentored Investigator Grant
Genome-Wide Profiling of 5-hydroxymethylcytosine on Cell-Free DNA
-
Anne M. van Harten, PhD,
Thomas Jefferson University
Mentored Investigator Grant
Targeted MDM2 Degradation as a Novel Treatment for Ovarian Cancer
-
Bojana Stefanovska, PhD,
University of Minnesota Twin Cities
Mentored Investigator Grant
APOBEC3B and DNA Repair as Synthetic Lethal Combinations in CCOC
-
Sammy Ferri-Borgogno, PhD,
MD Anderson Cancer Center
Mentored Investigator Grant
Spatially-Resolved Cellular and Transcriptome Analyses of Ovarian Cancer
-
Sridevi Challa, PhD,
UT Southwestern Medical Center
Mentored Investigator Grant
Role of Ribosomal Protein Mono(ADP-ribosyl)ation in Protein Quality Control
-
Benoît Bragantini, PhD,
Mayo Clinic
Mentored Investigator Grant
Probing Homologous Recombination DNA Repair Factors in Chromatin by cryo-EM
-
Ronja Anugwom, PhD,
MD Anderson Cancer Center
Mentored Investigator Grant
Determine Resistance Mechanisms to ATR Inhibition in Ovarian Cancers
-
Ichiko Kinjyo, MD, PhD,
University of New Mexico
Early Career Investigator Grant
A Novel Mechanism for the Immunomodulatory Effects of PARP-inhibitor
-
Arun Kanakkanthara, PhD,
Mayo Clinic
Early Career Investigator Grant
Exploiting a Metabolic Dependency of PARPinhibitor-Resistant Ovarian Cancer
-
Liya Ding, PhD,
Dana Farber Cancer Institute
Early Career Investigator Grant
Targeting Therapeutic Resistance to PARP Inhibition in Ovarian Cancer
-
Sandra Cascio, PhD,
Magee-Womens Research Institute
Early Career Investigator Grant
EGFL6 as a New Regulator of Myeloid Cell Expansion and Function in HGSOC
-
Martin Cannon, PhD,
University of Arkansas for Medical Sciences
Collaborative Research Development Grant
Understanding and Targeting Myeloid Populations in Ovarian Cancer
-
Ivan Ahel, PhD,
University of Oxford
Collaborative Research Development Grant
Exploiting PARP-Modulating Enzymes in Ovarian Cancer Therapy
-
Wei Zhou, PhD,
The Wistar Institute
Mentored Investigator Grant
Targeting the mevalonate pathway in ARID1A-mutated ovarian cancer
-
Xueyang Yu, PhD,
Massachusetts Institute of Technology
Mentored Investigator Grant
Macrophage Control of the Microenvironment Drives HGSOC Progression